Frontier Medicines Funding & Investors
Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins, making them accessible to small-molecule drug discovery and development, enabling patients to consume breakthrough medicines that redefine the course of debilitating diseases.
frontiermeds.comTotal Amount Raised: $324,000,000
Frontier Medicines Funding Rounds
Series C
$80,000,000
Series C Investors
Deerfield ManagementDroia VenturesDCVC BioGalapagosRa Capital ManagementMPM CapitalSeries B
$88,500,000
Series B Investors
Woodline PartnersRa Capital ManagementMPM CapitalDeerfield ManagementSphera Global Healthcare FundArrowMark PartnersDeep Track CapitalDroia VenturesDriehaus Capital ManagementDCVC BioSeries B
$88,500,000
Series B Investors
Ra Capital ManagementWoodline PartnersSphera Global Healthcare FundArrowMark PartnersDeep Track CapitalDriehaus Capital ManagementSeries A
$67,000,000
Series A Investors
Deerfield ManagementDroia VenturesMPM CapitalRa Capital ManagementDCVC BioBerkeley Catalyst Fund
Funding info provided by Diffbot.